Previous 10 | Next 10 |
home / stock / cgn:cc / cgn:cc news
Policy paper published by UK's leading dementia research charity emphasizes importance of early detection in dementia diagnosis, citing Cognetivity's CognICA(TM) as an innovative solution for use in primary care Vancouver, British Columbia--(Newsfile Corp. - December 13, 2022) - Cognetivity Neu...
Both announcements signal company's intentions for US commercial expansion with FDA-registered, market-ready brain health screening platform Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (...
Cognetivity's CognICATM Tool Has Been Selected by Biotech Giant Roche for Presentation to Roche Staff Vancouver, British Columbia--(Newsfile Corp. - November 7, 2022) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Cognetivity"), a technology com...
Funding Round Oversubscribed and Brings in Leading Middle East Institutional Investor as Key Shareholder and Provides Funds for the Company's Commercial Expansion Vancouver, British Columbia--(Newsfile Corp. - October 27, 2022) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB:...
Vancouver, British Columbia--(Newsfile Corp. - October 7, 2022) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Cognetivity") is pleased to announce, that it intends to complete a non-brokered private placement of up to 10,344,828 convertible pr...
Cognetivity's CognICA(TM) Tool to be Deployed to Detect Traumatic Brain Injury and Mental Health Issues on a Broad Scale for National US Healthcare Operator Vancouver, British Columbia--(Newsfile Corp. - September 20, 2022) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (F...
The Company's CognICA(TM) Tool to be Deployed in Baylor College of Medicine's Pivotal Study Involving the World's Largest Ethnically-Diverse Population with Obsessive Compulsive Disorder Vancouver, British Columbia--(Newsfile Corp. - September 13, 2022) - Cognetivity Neurosciences Ltd. (CS...
Cognetivity Neurosciences Launches Paid Pilot Project with MS&AD Group Companies Cognetivity Neurosciences Launches Paid Pilot Project with MS&AD Group Companies Canada NewsWire The Company's Personal Brain Health Tracking Technology to be Trialed by Ja...
Cognetivity Neurosciences Enters Asia Via Pilot Agreement with Leading Singaporean Senior Care Network Canada NewsWire Cognetivity's CognICA TM platform to be deployed within the extensive network of senior care facilities in Singapore operated by Lions Befri...
Cognetivity Neurosciences CFO to Speak at InterSystems Global Summit in Seattle on June 23, 2022 Canada NewsWire Dr. Thomas Sawyer is set to Deliver a Keynote Speech Alongside Senior Executives from InterSystems and Leading US Healthcare Organizations at the Heal...
News, Short Squeeze, Breakout and More Instantly...
Cognetivity Neurosciences Ltd. Company Name:
CGN:CC Stock Symbol:
CNQC Market:
Cognetivity Neurosciences Ltd. Website:
Velan Inc. Subordinate Voting Shares (VLN:CA) is expected to report for Q1 2025 GoldMining Inc. (GOLD:CA) is expected to report $-0.02 for Q2 2024 Blue Star Gold Corp. (BAU:CA) is expected to report for Q2 2024 Organigram Holdings Inc. (OGI:CA) is expected to report $-0.07 for Q3 2024...
Richelieu Hardware Ltd. (RCH:CA) is expected to report $0.42 for Q2 2024 Goodfellow Inc. (GDL:CA) is expected to report for Q2 2024 Centamin plc Ordinary Shares (CEE:CA) is expected to report for Q1 2024 Velan Inc. Subordinate Voting Shares (VLN:CA) is expected to report for Q1 2025 ...
Canadian Investment Regulatory Organization Trading Halt - CGN Canada NewsWire VANCOUVER, BC , June 6, 2024 /CNW/ - The following issues have been halted by CIRO: Company: Cognetivity Neurosciences Ltd. CSE Symbol: CGN All Issues: Yes Reason: Cease Tr...